Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared a post on LinkedIn:
“Happy to throwback 5 years ago when we published our work looking at the prevalence and prognostic impact of comorbidities and bloodindices in sarcomas.
This was based on a 4000+ patients’ dataset from HongKong.”
More posts featuring Herbert Loong on OncoDaily.